Of the multitude of growth factors that regulate angiogenesis, VEGF is believed to be the most important, whereas exon-deleted variants of ER-alpha, such as ERDelta3, a variant frequently overexpressed in breast cancer, may exert an undesirable effect, contributing significantly to VEGF production and thus exacerbating tumor growth in vivo [23]. Here, VEGFA is linked to breast cancer.